人及小鼠肝细胞膜载脂蛋白 CⅢ受体的研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家教委博士点科学基金及纽约中华医学基金部分资助课题.


Study of apoC Ⅲ-Binding Sites of Human and Mouse Hepatic Plasma Membranes
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    125I 标记载脂蛋白 CⅢ (apoCⅢ)为配体,采用聚乙二醇沉淀分离法,建立了小鼠肝细胞膜 apoCⅢ 受体(结合位点)放射分析法,并对人及小鼠肝细胞膜 apoCⅢ结合位点的特性进行了研究.

    Abstract:

    A specific,sensitive and simple radioligand binding assay for apoCⅢ-binding sites of hepatic plasma membranes has been established by separation of B/F with PEG.Addition of increasing concentration of 125Ⅰ-labeled apoCⅢ to human hepatic plasma membranes revealed saturation binding to membranes with a Kd of 0.31μmol/L(3.1×10-7mol/L) and binding maximum of 1.74μg/mg of membrane protein.In displacement studies using unlabeled apoCⅢ and isolated lipoproteins HDL,LDL and VLDL,only apoCⅢ and VLDL effectively competed with 125Ⅰ-apoCⅢ for membrane binding sites. The binding of 125Ⅰ-apoC l to human liver plasma membranes was Ca2+-independent and was abolished when plasma membranes were treated with trypsin. The characteristics of apoC Ⅲ-binding sites of mouse liver plasma membranes was similar to that of human liver plasma membranes with an exception of binding maximum of 1.52μg/mg of membrane protein.

    参考文献
    相似文献
    引证文献
引用本文

方定志,刘秉文.人及小鼠肝细胞膜载脂蛋白 CⅢ受体的研究[J].生物化学与生物物理进展,1993,20(3):199-203

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:1992-03-11
  • 最后修改日期:1992-05-14
  • 接受日期:
  • 在线发布日期:
  • 出版日期: